Aristotle Capital Boston LLC Sells 84,652 Shares of Herbalife Ltd $HLF

Aristotle Capital Boston LLC decreased its holdings in shares of Herbalife Ltd (NYSE:HLF) by 9.7% during the 4th quarter, Holdings Channel reports. The firm owned 788,588 shares of the company’s stock after selling 84,652 shares during the quarter. Aristotle Capital Boston LLC’s holdings in Herbalife were worth $10,165,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. AQR Capital Management LLC raised its stake in Herbalife by 236.8% during the 1st quarter. AQR Capital Management LLC now owns 133,245 shares of the company’s stock worth $1,150,000 after buying an additional 93,686 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Herbalife by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,964 shares of the company’s stock worth $517,000 after purchasing an additional 2,523 shares during the last quarter. Empowered Funds LLC raised its stake in shares of Herbalife by 12.9% in the first quarter. Empowered Funds LLC now owns 30,301 shares of the company’s stock worth $261,000 after purchasing an additional 3,474 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Herbalife by 3.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 210,904 shares of the company’s stock worth $1,820,000 after purchasing an additional 6,747 shares during the last quarter. Finally, Envestnet Asset Management Inc. purchased a new stake in shares of Herbalife in the second quarter worth approximately $118,000.

Insider Buying and Selling at Herbalife

In other Herbalife news, insider Frank Lamberti sold 134,982 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $13.50, for a total transaction of $1,822,257.00. Following the completion of the transaction, the insider directly owned 36,624 shares of the company’s stock, valued at approximately $494,424. This represents a 78.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Troy Hicks sold 38,377 shares of the stock in a transaction on Monday, May 18th. The shares were sold at an average price of $12.93, for a total value of $496,214.61. Following the transaction, the chief operating officer directly owned 9,062 shares of the company’s stock, valued at approximately $117,171.66. This trade represents a 80.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 191,296 shares of company stock valued at $2,551,678. 5.13% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Zacks Research downgraded Herbalife from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Wall Street Zen raised Herbalife from a “buy” rating to a “strong-buy” rating in a research report on Saturday, April 18th. Citigroup reaffirmed a “buy” rating and set a $21.00 price target (up from $17.00) on shares of Herbalife in a research report on Thursday, February 19th. Weiss Ratings raised Herbalife from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday. Finally, Royal Bank Of Canada decreased their price target on Herbalife from $17.00 to $16.00 and set a “sector perform” rating for the company in a research report on Tuesday, April 28th. Three analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $17.80.

Herbalife Trading Down 1.5%

Shares of NYSE HLF opened at $11.65 on Thursday. The stock has a fifty day simple moving average of $13.86 and a two-hundred day simple moving average of $14.87. Herbalife Ltd has a 1-year low of $7.56 and a 1-year high of $20.40. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of 5.11, a price-to-earnings-growth ratio of 0.70 and a beta of 0.88.

Herbalife (NYSE:HLF) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.61 by $0.03. Herbalife had a negative return on equity of 41.47% and a net margin of 4.67%.The business had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same period in the prior year, the company earned $0.59 earnings per share. Herbalife’s revenue was up 7.8% compared to the same quarter last year. Analysts forecast that Herbalife Ltd will post 2.47 EPS for the current year.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.